Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Titan Pharmaceuticals Inc (NASDAQ:TTNP)

5.01
Delayed Data
As of Jul 22
 +0.01 / +0.20%
Today’s Change
2.57
Today|||52-Week Range
10.00
+12.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues7.1M10.5M3.6M1.7M
 
 
 
 
 
Depreciation And Amortization17.0K107.0K353.0K358.0K
 
 
 
 
 
 
Operating ExpensesGross Income7.1M--3.3M--
 
 
 
General Expenses15.5M11.3M6.8M8.1M
 
 
 
 
 
Research And Development10.6M8.3M4.1M4.7M
 
 
 
 
 
Total Operating Expenses15.5M11.4M7.1M8.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.4M-891.0K-3.5M-6.8M
 
 
 
 
 
Extraordinary Credit0.0012.6M1.1M0.00
 
 
 
Extraordinary Charge-1.8M0.000.00-4.5M
 
 
 
Interest Expense On Debt4.9M1.6M--0.00
 
 
 
Other Expenses-183.0K-467.0K-11.0K-8.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.2M9.7M-2.4M-11.3M
 
 
 
 
 
Net Income-15.2M9.7M-2.4M-11.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.1M14.9M17.1M20.1M
 
 
 
 
 
Shares To Calculate EPS Diluted12.1M15.0M17.1M20.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.26$0.55-$0.22-$0.56
 
 
 
 
 
EPS Diluted-$1.26$0.55-$0.22-$0.56